TY  - CHAP
M1  - Book, Section
TI  - Pregnancy as a Window to Future Health
A1  - Smith, Graeme N.
A1  - Murphy, Malia S. Q.
A1  - Nerenberg, Kara A.
A2  - Pacheco, Luis D.
A2  - Saade, George R.
A2  - Hankins, Gary D.V.
PY  - 2015
T2  - Maternal Medicine
AB  - Pregnancy  has  been  likened  to  a  cardiovascular  stress  test  in  that  the  development  of  certain  common  pregnancy  complications  have  the  potential  to  reveal  a  woman’s  vascular  or  metabolic  susceptibility  for  future  diseases.1  Indeed,  the  degree  to  which  a  woman  “fails”  the  pregnancy  stress  test  and  the  number  of  times  the  woman  “fails”  it,  in  all  likelihood  reflects  not  only  her  risk  for  future  cardiovascular  disease  (CVD)  but  the  timeframe  over  which  it  is  likely  to  develop.2  The  2011  update  to  the  American  Heart  Association’s  Effectiveness-Based  Guidelines  for  the  Prevention  of  Cardiovascular  Disease  in  Women3  now  includes  certain  common  pregnancy  complications  (eg,  preeclampsia,  gestational  hypertension,  gestational  diabetes,  etc)  as  key  components  when  screening  women  at  risk  for  heart  disease  and  stroke.  Importantly,  the  development  of  these  pregnancy  complications  not  only  identifies  women  at  increased  risk  for  future  CVD  but  also  can  accurately  identify  women  who  already  have  underlying,  often  unrecognized,  cardiovascular  risk  factors  (CVRs).4,5  As  such,  we  have  coined  the  term  “Pregnancy-related  cardiovascular  risk  indicators”6  (Table  38-1),  the  development  of  which  provides  an  early  window  of  opportunity  for  postpartum  CVR  identification  and  interventions  that  could  lead  to  a  reduction  in  risk  of  future  CVD  and  potentially  improved  outcomes  in  subsequent  pregnancies.2  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/16
UR  - obgyn.mhmedical.com/content.aspx?aid=1115521487
ER  -